Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Tapendadol (ausschl. Wirkstärke 25 mg in der Normgröße N3), ATC N02AX06 f. d. Z. 01.11.24 - 31.10.26
Original language: German
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Winners
- 1 A Pharma GmbH
- Contract value
- no value published
- Bids received
- 4
- Published
- 2 Jul 2026
- Awarded
- 1 Nov 2024
- Contract start
- 1 Nov 2024
- Contract end
- 14 Nov 2025estimated
- Region
- Hamburg